🔎 Trials Near Me

Akèy › Depresyon › Alabama

Etid klinik pou Depresyon nan Alabama

14 etid pou Depresyon ap chèche patisipan nan sit nan Alabama.

Vil nan Alabama

Tèks ofisyèl etid la (Anglè)

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • UAB Psychiatry and Behavioral Neurology, Birmingham
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • UAB, Psychiatry and Behavioral Neurology, Birmingham
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • University of Alabama at Birmingham, Huntsville Regional Medical Campus, Huntsville
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 8, 2026 · NCT07076407

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

  • Birmingham VA Medical Center, Birmingham, AL, Birmingham
  • Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07226232

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Huntsville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06911112

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Huntsville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents

  • University of Alabama at Birmingham, Birmingham
  • UAB Huntsville Regional Medical Campus, Huntsville
Ap rekriteVolontè an sante akeyi
Laj 10 a 24 · Tout sèks · Mizajou Jul 13, 2026 · NCT05437588

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

  • University of Alabama at Birmingham, Birmingham
  • UAB Huntsville Regional Medical Center, Huntsville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03887715

Investigating Dynamic Interactions in Distributed Cognitive Control Networks

  • University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT05927974

Low Voltage Electrical Stimulation for Depression in Parkinson's Patients

  • University of South Alabama, Mobile
Ap rekrite
Laj 19 a 65 · Tout sèks · Mizajou Apr 6, 2026 · NCT06467695

MicroRNA Correlates of Childhood Maltreatment and Suicidality

  • University of Alabama at Birmingham, Birmingham
  • UAB Huntsville Regional Medical Campus, Huntsville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Mar 30, 2026 · NCT04923685

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

  • University of Alabama Birmingham Hospital, Birmingham
Ap rekrite
Laj 12 a 22 · Tout sèks · Mizajou Oct 30, 2025 · NCT06232304

Digital Intervention for Physical Activity

  • Kinesiology Building, Auburn
Ap rekrite
Laj 19 a 40 · Tout sèks · Mizajou Sep 18, 2025 · NCT07130734

Strengthening Health and Insight in New Educators

  • University of Alabama, Tuscaloosa
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 2, 2025 · NCT06745934

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.